https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
$ 49.5 Weighted average diluted shares 86.7 Impact to diluted shares from January
$ 45.3 Weighted average diluted shares 91.8 Impact to diluted shares from January
$ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
$ 49.5 Weighted average diluted shares 86.7 Impact to diluted shares from January
$ 45.3 Weighted average diluted shares 91.8 Impact to diluted shares from January
$ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January
https://www.avient.com/investors/stock-information
Reporting & SEC Filings
Consensus Earnings Estimates
https://www.avient.com/investor-center/news/polyone-announces-leadership-appointments
March 16, 2020
March 16, 2020
earned a bachelor's degree in applied chemistry from
https://www.avient.com/investor-center/news/avient-updates-third-quarter-and-full-year-2022-forecast
January 1, 2022
January 1, 2021
forward-looking non-GAAP financial measures, such as outlook for adjusted earnings
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
1, 2019 – December 31, 2019 25% $2.52 $2.42 71% January 1, 2020 – December
31, 2020 25% $1.94 $1.90 95% January 1, 2021 – December 31, 2021 25% $2.15 $3.05
1, 2019 – December 31, 2019 25% $2.35 $2.52 $2.77 $2.42 71% January 1, 2020
https://www.avient.com/news/polyone-announces-strong-fourth-quarter-and-full-year-2013-results
January 28, 2014
$0.03 reported in the fourth quarter of 2012.
In this press release, statements that are not reported financial results or
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
for periods prior to the Acquisition Date, as if the transaction occurred on January
2020 2023E $265 $358 $726 $730 2016 2018 2020 2023E 8-12% 8-10% 8-10% 5% Sustainable
financing and paydown of debt with net proceeds from the Distribution sale. 2 AVNT January
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
for periods prior to the Acquisition Date, as if the transaction occurred on January
Adjusted EBITDA $ 107.4 $ 132.2 $ 591.7 $ 599.7 * Pro forma adjustment for January
Pro forma EBITDA $ 107.4 $ 132.2 $ 591.7 $ 599.7 * Pro forma adjustment for January
https://www.avient.com/news/avient-site-taiwan-earns-iso-13485-accreditation-fourth-source-mevopur-medical-grade-materials
Homepage
//
News Center
//
Avient Site in Taiwan Earns ISO 13485 Accreditation
January 19, 2022
TAOYUAN, Taiwan – January 19, 2022 – Avient Corporation, a premier provider